KLRC1 and plasma cell myeloma: Interestingly, during NK cell expansion, NKG2A is significantly upregulated [82, 83], and high HLA-E expression on multiple myeloma cells can limit CAR-NK cell function, which can be restored with NKG2A blockade [84].